Register Now
Youtube Linkedin Facebook
dxpx general logo white text
McCormick Place Convention Center, Chicago, IL | July 29th - July 31st, 2025

DxPx U.S. 2025 Registration

DxPx at ADLM 2025

Facilitating Startup-Industry-Investor Collaborations in Diagnostics & Digital Health, and Biotools

DxPx, in collaboration with ADLM, is hosting our DxPx Startup City at ADLM in Chicago. This initiative helps diagnostics, digital health, and life science tools startups connect with potential investors and industry partners. The event consists of:

DxPx Startup City at ADLM (Exhibition)
  • A dedicated startup exhibition for 32 startups in the heart of ADLM expo.
  • Includes:
    • Booth space in DxPx Startup City
    • Two tickets for ADLM expo
    • Free Access to the DxPx virtual partnering platform
    • Participation in curated investor & industry networking at DxPx Rooftop reception
    • Promotion in the worldwide DxPx & ADLM communications
  • Excludes:  Service providers (CROs, CDMOs, consultants)


Standard Pricing: $3,650 per startup

Learn more about Startup City here. 


DxPx Investors-only Rooftop Reception. Connect with peers and discuss deal-flow,  challenges, opportunities and enjoy some great cocktails with a view over Chicago.

Date: Tuesday, July 29th

Location: Chicago Hilton, VU Rooftop Bar (150 participants limit)

Cost: $100 per participant

Exclusive to:

  • Industry partners (excluding service providers)
  • Institutional investors


Why attend?

This is a highly curated networking opportunity where startups, industry partners, and investors can connect in an informal yet strategic setting.

How to Register

Attendance at this event is highly limited. Please fill out our registration form to confirm your interest in the event and we will be in touch with your registration confirmation.

REGISTER FOR INVESTOR-ONLY ROOFTOP RECEPTION HERE. 

Virtual Partnering (Two Weeks) – Global Matchmaking
  • Two-week AI-powered partnering connecting ADLM attendees, DxPx participants, and external stakeholders.
  • Enables 1-on-1 virtual meetings for business development, investments, and strategic partnerships.
  • Open to external participants beyond ADLM exhibitors.

Why participate?

  • Extended networking beyond ADLM
  • Scheduled 1-on-1 meetings with key industry players
  • Access to DxPx’s AI-powered matchmaking platform
Download Our Brochure for Startups

Important Note on Ticket Categories

At DxPx, companies focusing on providing services (rather than producing or developing their own tangible assets) are classified as Service Providers. This includes, but is not limited to:

  • Fundraising agencies
  • Corporate finance advisory firms
  • Strategy consultancies
  • CROs, CMDOs
  • Engineering agencies


Such companies must register under the Service Provider ticket category. They are not eligible for Startup, Industry, or Investor tickets or any discounts for these.

As outlined in our general terms and conditions, DxPx reserves the right to reassign tickets to the correct category and charge the applicable price difference. We kindly ask all participants to register under the appropriate category to avoid additional charges.

Thank you for your understanding and cooperation.

Note: A Standard Startup Ticket is required to attend the networking/lunch events. 

Tickets

The numbers below include tickets for this event already in your cart. Clicking "Get Tickets" will allow you to edit any existing attendee information as well as change ticket quantities.
On Sale
DxPx US '25 Startup City Booth
Booth space on the floor of ADLM | 2 tickets to the ADLM Expo | Access to DxPx Rooftop Reception Tickets | 2 User Logins to DxPx Partnering Platform
$ 3,650 $ 3,285
27 available
DxPx US '25 Virtual Partnering Platform Access - Non ADLM Exhibitor
Startup City exhibitors receive free virtual partnering platform access with their booth purchase.
$ 250
Unlimited
DxPx US '25 Virtual Partnering Platform Access - ADLM Exhibitor
Please include your ADLM booth number in the "Other Notes" section on the checkout page.
$ 0
Unlimited
Quantity: 0
Total: $ 0

Investors & Industry Companies in Attendance at DxPx Events

Date & Location:

July 29-31, 2025 in Chicago, IL at the ADLM 2025 

McCormick Place Convention Center
2301 South King Dr., Chicago, IL 60616

Don't miss our investor conferences & early-stage investing events:

dxpx us adlm logos
DxPx US

DxPx Industry & Investor Conference US:
4 Days In-Person

July 29 - Aug. 1, 2024
Chicago, IL
In the ADLM

Stay up to date and sign up for our latest news:

Next: DxPx U.S. 2025
  • 3 Days In-Person
  • July 29 - 31, 2025
  • McCormick Place
    Convention Center
    Chicago, Illinois, USA
Next: DxPx EU 2026
  • 2 Days In-Person
  • Reception: February 5, 2026
    Partnering Day & 42PLUS1:
    February 6, 2026
  • Munich, Germany
Download Brochure
DxPx media
Useful links

© Copyright DxPx 2025. All Rights Reserved.

Youtube Linkedin Facebook

Oliver Dick

Oliver brings 30+ years of experience in the life sciences industry, has worked in pharma, biotechnology and in vitro diagnostics. His areas of expertise fall under Supply Chain Management, Planning, Production, QC, QA, Engineering, Technology Transfer and Process Improvement. Amongst his vast experience, Oliver held functions such as Vice President of Global Manufacturing at QIAGEN, Chief Operating Officer at Miltenyi Biotec or Chief Operating Office of Resolve Biosciences. He demonstrated exceptional leadership and expertise in driving manufacturing excellence on a global scale.

Oliver has a proven ability to streamline processes, optimize production efficiency, and foster a culture of innovation. He was responsible for strategy development, scaling, cost control and quality and was part of multiple M&A projects and transfer of many new products from acquisition or own development. Today Oliver offers his expertise mainly through his own Consultancy Service Company ODICON.

Experience

Christoph Brandenberger

Christoph Brandenberger is a Managing Director at BGL and a leader in the firm’s Diagnostics, Research Tools & Medical Devices investment banking group. He has more than 20 years of experience in all aspects of mergers and acquisitions, commercialization and partnering agreements, and private placements.

A native of Austria and fluent in German, Christoph’s investment banking experience, coupled with his background in international business, has made him a sought-after advisor in both the domestic and international healthcare markets.

Prior to joining BGL, Christoph served as managing director for Healthios Capital Markets, LLC. Christoph started his career as a financial analyst for Bank of America Securities.

Experience

John Riddle

John Riddle is a Managing Director and member of the BGL Executive Committee. He has more than 30 years of investment banking and capital markets experience, advising clients across a broad spectrum of mergers and acquisitions, capital markets activities, and strategic assignments.

John leads BGL’s advisory activities in the Healthcare & Life Sciences investment banking group, which comprises both corporate investment banking and real estate capital markets capabilities. Together with his team, John maintains an ongoing coverage effort with broad activity across several sectors, including health facilities, physician services, and ancillary providers; diagnostics and research tools; medical device and products; and select healthcare technology verticals, including payor services, data analytics, and clinical automation.

Experience

Dr. Mirko Stange

Born in Bremen, Germany in 1974, Dr. Mirko Stange is a diagnostics and life sciences expert with a proven track record in turning around and commercializing innovations. He possesses extensive executive management experience, having led diagnostics and biotech startups, as well as developing and conducting consulting products. Following the completion of his Ph.D. in Biochemistry and Biophysics at the University of North Carolina at Chapel Hill, Dr. Stange began his career in 2004 at the strategy consultancy McKinsey. Subsequently, he worked with the turnaround-specialized advisory firm Droege & Comp., primarily serving clients from the pharma and chemistry industry in Germany and Switzerland.

In 2008, he founded an independent Life Sciences consultancy in Germany where, to date, he leads and directs a team of international experts. This team identifies and funds SMEs with high potential for national and international leverage. In addition to his over ten years of experience in independent corporate finance and management consulting, Mirko Stange provides interim management services to selected clients. To date, three companies co-founded and managed/advised by Dr. Stange have been successfully exited. Leveraging his scientific background, he is also a named inventor on several granted and pending patents.

Experience

FName LName

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Experience